<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230202057310N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-12-22</date_registration>
      <primary_sponsor>Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan</primary_sponsor>
      <public_title>Undenatured collagen type 2 supplementation and knee strengthening exercises in knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Synergistic effect of undenatured collagen type 2 supplementation and knee strengthening exercises in knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-01-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>377</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/80825</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: This randomization will be done by computer-generated numbers to ensure fairness. Medications will be given in numbered white boxes, each with a unique medication number. The treatment codes will be kept by the principal investigator, Blinding description: Statistical analyser and outcome assessor will be kept blind so that the result obtained will be without biasness.</study_design>
      <phase>1</phase>
      <hc_freetext>Knee osteroarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Will receive 40 mg/day of undenatured collagen type II supplementation. Intervention 2: Intervention group: Will be given a standardized knee-strengthening exercise program [specify duration and frequency, e.g., three times per week for 45 minutes].The knee-strengthening exercise program focused on improving muscle strength, joint stability, and functional mobility. It included:•	Warm-up: [e.g., 5 minutes of light cycling or walking].•	Strengthening exercises: Quadriceps setting, hamstring curls, straight leg raises, and step-ups. Each exercise was performed in sets of 10 repetitions with progressive intensity over the study period.•	Cool-down: [specify activities, e.g., 5 minutes of stretching or slow walking].Participants were supervised by trained physiotherapists to ensure adherence and proper technique. Intervention 3: Intervention group: Will recieve UC-II supplementation and participated in the knee-strengthening exercise program.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is N/A</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maliha Khalid Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Multan</address>
        <city>MULTAN</city>
        <country1>Pakistan</country1>
        <zip>66000</zip>
        <telephone>+92 333 6120602</telephone>
        <email>malihatareen1997@gmail.com</email>
        <affiliation>Muhammad  Institute  of  Medical  and  Allied  Sciences,  Multan,  Pakistan.</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Imran Ahmad Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Old shuja Abad road Multan</address>
        <city>Multan</city>
        <country1>Pakistan</country1>
        <zip>66000</zip>
        <telephone>+92 333 6120602</telephone>
        <email>imran.ahmad@mnsuam.edu.pk</email>
        <affiliation>Muhammad Nawaz Sharif University of Agriculture Multan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adults aged between 35–65  years.
Diagnosed with mild-to-moderate knee osteoarthritis based on:  Radiographic confirmation (Kellgren-Lawrence grade :1–3).
Experiencing knee pain for at least 3 months
Able to perform physical activity and follow an exercise regimen
Willing to take undenatured collagen type II supplementation as prescribed
Not taking any other osteoarthritis-related medications or willing to maintain a washout period of at least  2 weeks  prior to enrollment
Provided written informed consent to participate in the study.</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Diagnosed with severe knee osteoarthritis  (Kellgren-Lawrence grade 4).
History of knee surgery  or any intra-articular injections (e.g., corticosteroids, hyaluronic acid) in the past  6 months.
Currently using immunosuppressive therapy or corticosteroids
Pregnancy, breastfeeding, or planning to become pregnant during the study
Presence of serious systemic diseases
Known allergy or intolerance  to collagen supplements or any ingredients in the intervention product
Presence of other  types of arthritis such as rheumatoid arthritis, gout, or infectious arthritis.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M19.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Primary osteoarthritis of other joints</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Will receive 40 mg/day of undenatured collagen type II supplementation.</i_keyword>
      <i_keyword>Intervention group: Will be given a standardized knee-strengthening exercise program [specify duration and frequency, e.g., three times per week for 45 minutes].The knee-strengthening exercise program focused on improving muscle strength, joint stability, and functional mobility. It included:•	Warm-up: [e.g., 5 minutes of light cycling or walking].•	Strengthening exercises: Quadriceps setting, hamstring curls, straight leg raises, and step-ups. Each exercise was performed in sets of 10 repetitions with progressive intensity over the study period.•	Cool-down: [specify activities, e.g., 5 minutes of stretching or slow walking].Participants were supervised by trained physiotherapists to ensure adherence and proper technique.</i_keyword>
      <i_keyword>Intervention group: Will recieve UC-II supplementation and participated in the knee-strengthening exercise program.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Osteophytes. Timepoint: 12 weeks. Method of measurement: Knee Xray.</prim_outcome>
      <prim_outcome>Pain, stiffness and ADLs. Timepoint: 12 weeks. Method of measurement: NPRS and WOMAC Scale.</prim_outcome>
      <prim_outcome>Knee ROM. Timepoint: 12 weeks. Method of measurement: Goniometry.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Knee injury outcome. Timepoint: 12 weeks. Method of measurement: Knee injury outcome score (KOOS).</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: 12 weeks. Method of measurement: SF-36.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-11-21</approval_date>
        <contact_name>The Institutional Ethical Committee of Muhammad Institute of Medical and Allied Sciences</contact_name>
        <contact_address>Bosan Road Multan Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
